NEW YORK (GenomeWeb News) – Cepheid has hired Michael Bates to be VP of oncology research and development. Bates will be responsible for the company's microRNA program and the development and preclinical evaluation of its oncology testing portfolio.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.